Experts convened by the National Institutes of Health (NIH) have identified five elements of a brain-based condition that has emerged as a leading cause of vision impairment starting in childhood in the United States and other industrialized nations.
Amgen wants in on obesity. But it’s still working on rare disease, too
Amgen touted its rare disease strategy on Thursday, highlighting the financial potential of both current blockbusters and other drugs in its pipeline. The spotlight on
February 24, 2024